Enveric Biosciences Announces Reverse Stock Split

Group 1 - The article discusses forward-looking statements related to future events or performance of the company, emphasizing that these statements are not historical facts [1] - It highlights that forward-looking statements may include terms such as "plans," "expects," "intends," and "anticipates," indicating management's beliefs and assumptions about the future [1] - The article notes that actual results could differ materially from these forward-looking statements due to various factors affecting the company's operations and market conditions [1] Group 2 - The company must remain listed on Nasdaq and finalize its IND filing with the U.S. Food and Drug Administration to proceed with its clinical programs [1] - Successful execution of clinical trials and establishing the efficacy and safety of potential products are critical for the company's future [1] - The company faces challenges in securing necessary governmental approvals, obtaining funding, and managing growth effectively [1]